Biosynthetic Psilocybin

PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) reported its unaudited interim financial results for the three and nine-month period ended September 30, 2022. PsyBio, a fully integrated and intellectual property-driven biotechnology company, develops new psycho-targeted therapies...